News Release

Infant's Gaze May Be an Early, but Subtle, Marker for Autism Risk

September 1, 2010
Research Findings Show Subtle Differences that Parents and Professionals May Easily Overlook

(Baltimore, MD) Kennedy Krieger Institute announced today new study results showing an early marker for later communication and social delays in infants at a higher-risk for autism may be infrequent gazing at other people when unprompted. Published in the September issue of the Journal of Child Psychology and Psychiatry, the study also found that six-month-old high-risk infants demonstrated the same level of cause and effect learning skills when compared to low-risk infants of the same age.

On Your Mark, Get Set...ROAR for Autism!

March 21, 2011
Kennedy Krieger Institute's annual fundraiser raises critical funds for autism research

(Baltimore, MD)- On May 1, 2011, in an effort to raise awareness and critically needed funds for autism research, Kennedy Krieger Institute will host its seventh annual ROAR for Autism at Oregon Ridge Park in Cockeysville, MD. According to the U.S. Centers for Disease Control, the prevalence rate of autism, a complex, life-altering, developmental disorder, has risen to 1 in 110 children. Kennedy Krieger continues to be one of the nation's leaders in autism research, striving to provide earlier diagnosis and intervention.

New Study Affirms Handwriting Problems Affect Children with Autism into the Teenage Years

November 15, 2010
Kennedy Krieger Researchers Confirm Children with Autism Are Unlikely to Outgrow Handwriting Problems, Recommend Intervention Therapies

The handwriting problems that affect children with autism spectrum disorders (ASD) are likely to continue into their teenage years, according to a study from the Kennedy Krieger Institute in Baltimore, Md. The research is published in the November 16, 2010 issue of Neurology®, the medical journal of the American Academy of Neurology.

Local Wheelchair Basketball Team Finishes Second In Nation

April 11, 2011
Kennedy Krieger Institute's Bennett Blazers Return from National Wheelchair Basketball Championships with Second Place Finish, Numerous Individual Honors

(Baltimore, MD) - After four days of intense competition at the National Wheelchair Basketball Association's (NWBA) 63rd annual National Championship Tournament, a team from Baltimore was named the second-best Varsity team in the country. The Bennett Blazers, named for a founding mentor and part of the Kennedy Krieger Institute's Physically Challenged Sports Program, competed alongside more than 700 of the best athletes with physical disabilities from across the U.S. who traveled to Denver to play in one of six divisions.

Kennedy Krieger Institute Opens First Clinic for Albright Hereditary Osteodystrophy; Dr. Emily Germain-Lee Brings New Expertise and Research to the Institute

December 28, 2010
National news network to air story on families affected by this rare genetic condition

(Baltimore, MD) - Kennedy Krieger Institute announced the opening of a new clinic for the treatment and research of Albright hereditary osteodystrophy (AHO), a rare genetic disorder affecting the bones, skin and hormone-producing tissues. Under the direction of Dr. Emily Germain-Lee, the clinic will provide expert care to children and adults with the disorder, as well as conduct research to expand knowledge of AHO and identify new treatment options. Dr.

BWI 5k Run/2-Mile Family Fun Walk to Raise Funds for Children With Down Syndrome

August 23, 2010
24th annual BWI Run/Walk to benefit Kennedy Krieger Institute’s Down Syndrome Clinic

Sunday, September 26, 2010

(Baltimore, MD) -Northrop Grumman will once again partner with the BWI Airport and other local sponsors to host the 24th Annual BWI Run/Walk, which benefits the Kennedy Krieger Institute's Down Syndrome Clinic. The family friendly event features two courses, a 5K Run and a 2-Mile Family Fun Walk, as well as a raffles and other activities for all ages. In addition to runner and school challenge awards, there will also be entertainment, food, beverages, and impressive prizes.

Kennedy Krieger Institute's Down Syndrome Clinic Celebrates 20 Years

July 23, 2010
The event took place in the new Outpatient Center at 801 N. Broadway, overlooking the therapy garden.

On Friday, June 25 patients, families and staff joined Dr. George Capone to celebrate 20 years of achievements of the Down Syndrome Clinic at Kennedy Krieger Institute. The event took place in the new Outpatient Center at 801 N. Broadway, overlooking the therapy garden. Guests listened as Dr. Capone, Institute President & CEO Dr. Gary Goldstein, patients and staff shared stories and offered thanks for the decades of dedication found among the attendees.

NIH Expansion of Rare Diseases Clinical Research Network to Include Kennedy Krieger Institute

October 8, 2009
Sturge-Weber syndrome researchers at Kennedy Krieger to take part in one of nineteen consortia

Baltimore, MD-The National Institutes of Health announced this week funding for 19 research consortia as part of an expansion of the Rare Diseases Clinical Research Network (RDCRN), including a Brain Vascular Malformation Consortium. Dr. Anne Comi and her colleagues in the Hunter Nelson Sturge-Weber Center at Kennedy Krieger Institute have been funded to contribute to this consortium, which will be led by Dr. William Young at the University of California, San Francisco.

Brain Injury Program at Kennedy Krieger Institute Celebrates 30th Anniversary

October 6, 2009
Program’s history is one of advancing brain injury rehabilitation research and patient care

Baltimore, MD-Today, Kennedy Krieger Institute's brain injury program celebrates 30 years of advancing research and patient care. The program, one of the nation's leading brain injury rehabilitation programs, is known for its pioneering "continuum of care" model that provides for coordinated care across the inpatient, day-hospital, home and community settings and emphasizes re-integration of children into their home, school, and community.

Cancer Drug Found to Aid Cell Regeneration After Spinal Cord Injury

January 27, 2011
Taxol stabilizes growing nerve cells and reduces the barrier of scar tissue

(Baltimore, MD) - In a study published today in Science (e-publication ahead of print), a global research team reports that the cancer drug Taxol® (Paclitaxel) promotes the regeneration of injured nerve cells in the central nervous system (CNS) after spinal cord injury.

Syndicate content